SIDNEY BROWN-CAGGIANO: Open Payments
NPI 1154890564 · DOUGLASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,364 in 216 payments from 21 companies in 2025. Trend: 2023 $2,803 · 2024 $5,523 · 2025 $5,364
Food & beverage: $4,047Consulting: $1,140Education: $177
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $1,467 |
| ABBVIE INC. | 62 | $978 |
| LEO Pharma Inc. | 20 | $594 |
| Galderma Laboratories, L.P. | 28 | $348 |
| Novartis Pharmaceuticals Corporation | 15 | $236 |
| GENZYME CORPORATION | 6 | $225 |
| Amgen Inc. | 13 | $215 |
| Incyte Corporation | 12 | $213 |
| Janssen Biotech, Inc. | 7 | $194 |
| PFIZER INC. | 12 | $190 |
Products named: Bimzelx, SKYRIZI, ADBRY, DUPIXENT, RINVOQ, NEMLUVIO, OTEZLA, OPZELURA.
Industry payments across GA — which companies pay providers there.
